tradingkey.logo

KORU Medical Systems Inc

KRMD

4.039USD

+0.079+2.01%
Market hours ETQuotes delayed by 15 min
186.76MMarket Cap
LossP/E TTM

KORU Medical Systems Inc

4.039

+0.079+2.01%
More Details of KORU Medical Systems Inc Company
KORU Medical Systems, Inc. designs, manufactures, and markets proprietary portable and advanced medical devices primarily for the subcutaneous drug delivery market. The Company is focused on home and specialty infusion solutions. Its focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. The devices are used for infusions administered at home and in alternate care settings. Its infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
Company Info
Ticker SymbolKRMD
Company nameKORU Medical Systems Inc
IPO dateOct 27, 1993
CEOMs. Linda M. Tharby
Number of employees80
Security typeOrdinary Share
Fiscal year-endOct 27
Address100 Corporate Drive
CityMAHWAH
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code07430
Phone18454692042
Websitehttps://www.korumedical.com/
Ticker SymbolKRMD
IPO dateOct 27, 1993
CEOMs. Linda M. Tharby
Company Executives
Name
Name/Position
Position
Shareholding
Change
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.09M
+16.34%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
--
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
87.60K
+5.02%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
84.97K
+5.19%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
84.61K
+5.21%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+116.54%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
37.77K
+12.47%
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.09M
+16.34%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
--
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
87.60K
+5.02%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
84.97K
+5.19%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
84.61K
+5.21%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+116.54%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Domestic Core
6.93M
71.90%
International Core
2.43M
25.21%
Novel Therapies
278.45K
2.89%
By RegionUSD
Name
Revenue
Proportion
Domestic
7.21M
74.79%
International
2.43M
25.21%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Domestic Core
6.93M
71.90%
International Core
2.43M
25.21%
Novel Therapies
278.45K
2.89%
Shareholding Stats
Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Horton Capital Management LLC
12.70%
First Light Asset Management, LLC
10.13%
Topline Capital Management, LLC
7.80%
Tharby (Linda M)
4.52%
The Vanguard Group, Inc.
4.51%
Other
60.34%
Shareholders
Shareholders
Proportion
Horton Capital Management LLC
12.70%
First Light Asset Management, LLC
10.13%
Topline Capital Management, LLC
7.80%
Tharby (Linda M)
4.52%
The Vanguard Group, Inc.
4.51%
Other
60.34%
Shareholder Types
Shareholders
Proportion
Hedge Fund
23.51%
Investment Advisor/Hedge Fund
17.47%
Investment Advisor
13.19%
Individual Investor
8.29%
Pension Fund
0.92%
Research Firm
0.47%
Bank and Trust
0.09%
Insurance Company
0.03%
Other
36.03%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
181
28.37M
61.38%
+1.59M
2025Q1
185
26.98M
58.55%
-3.80M
2024Q4
166
28.05M
61.23%
-2.99M
2024Q3
157
26.45M
57.75%
-1.49M
2024Q2
155
27.99M
61.12%
-3.90M
2024Q1
138
29.57M
64.66%
-1.94M
2023Q4
141
31.83M
69.81%
-3.05M
2023Q3
138
32.73M
71.92%
-2.69M
2023Q2
140
33.07M
72.70%
-1.19M
2023Q1
149
31.99M
70.39%
-2.55M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Horton Capital Management LLC
5.87M
12.73%
-16.19K
-0.27%
Apr 02, 2025
First Light Asset Management, LLC
4.71M
10.22%
+259.46K
+5.82%
Apr 30, 2025
Topline Capital Management, LLC
3.82M
8.28%
-505.93K
-11.69%
Mar 31, 2025
Tharby (Linda M)
2.09M
4.53%
+293.63K
+16.34%
Apr 21, 2025
The Vanguard Group, Inc.
1.76M
3.82%
+6.48K
+0.37%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
181.51K
0.39%
-323.00
-0.18%
Mar 31, 2025
Geode Capital Management, L.L.C.
495.27K
1.07%
+32.09K
+6.93%
Mar 31, 2025
Meros Investment Management, LP
746.56K
1.62%
-18.99K
-2.48%
Mar 31, 2025
Archon Capital Management LLC
566.87K
1.23%
+377.97K
+200.09%
Mar 31, 2025
Manko (Joseph M JR)
517.20K
1.12%
--
--
Apr 02, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI